首页 正文

Review Drug safety. 2021 Oct;44(10):1033-1040. doi: 10.1007/s40264-021-01093-9 Q13.82025

Use of Primary Care Data in Research and Pharmacovigilance: Eight Scenarios Where Prescription Data are Absent

关于研究和药物警戒中初级保健数据的使用:当缺乏处方信息时的八种情况 翻译改进

Grace N Okoli  1, Puja Myles  2, Tarita Murray-Thomas  2, Hilary Shepherd  2, Ian C K Wong  3, Duncan Edwards  4

作者单位 +展开

作者单位

  • 1 Centre for Primary Care and Mental Health, Institute of Population Health Sciences, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Yvonne Carter Building, 58 Turner Street, London, E1 2AB, UK. g.okoli@qmul.ac.uk.
  • 2 Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory Agency, London, UK.
  • 3 Research Department of Practice and Policy, Centre for Medicines Optimisation Research and Education (CMORE), School of Pharmacy, University College London, London, UK.
  • 4 Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, London, UK.
  • DOI: 10.1007/s40264-021-01093-9 PMID: 34296384

    摘要 Ai翻译

    The use of primary care databases has been integral in pharmacoepidemiological studies and pharmacovigilance. Primary care databases derive from electronic health records and offer a comprehensive description of aggregate patient data, from demography to medication history, and good sample sizes. Studies using these databases improve our understanding of prescribing characteristics and associated risk factors to facilitate better patient care, but there ar... ...点击完成人机验证后继续浏览
    Copyright © Drug safety. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Drug safety

    缩写:DRUG SAFETY

    ISSN:0114-5916

    e-ISSN:1179-1942

    IF/分区:3.8/Q1

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Use of Primary Care Data in Research and Pharmacovigilance: Eight Scenarios Where Prescription Data are Absent